The MOTIVATE trials: maraviroc therapy in antiretroviral treatment-experienced HIV-1-infected patients. [electronic resource]
- Expert review of anti-infective therapy Nov 2012
- 1241-7 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
1744-8336
10.1586/eri.12.114 doi
Anti-Retroviral Agents--adverse effects CCR5 Receptor Antagonists Cyclohexanes--adverse effects Drug Therapy, Combination HIV Infections--drug therapy HIV-1--physiology Humans Maraviroc Randomized Controlled Trials as Topic Triazoles--adverse effects Viral Tropism